{"url_path":"/sec/ivf/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1417926/0001493152-26-029514-index.html","accession_number":"0001493152-26-029514","cik":"0001417926","ticker":"IVF","issuer_name":"INVO Fertility, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1417926/0001493152-26-029514-index.html","primary_entity_key":"0001417926","primary_entity_name":"INVO Fertility, Inc."},"word_count":2538,"has_tables":true,"body_markdown":"false\n--12-31\nQ1\n0001417926\n\n0001417926\n\n2026-01-01\n2026-03-31\n\n0001417926\n\n2026-06-22\n\n0001417926\n\n2026-03-31\n\n0001417926\n\n2025-12-31\n\n0001417926\n\nus-gaap:NonrelatedPartyMember\n\n2026-03-31\n\n0001417926\n\nus-gaap:NonrelatedPartyMember\n\n2025-12-31\n\n0001417926\n\nus-gaap:RelatedPartyMember\n\n2026-03-31\n\n0001417926\n\nus-gaap:RelatedPartyMember\n\n2025-12-31\n\n0001417926\n\nIVF:SeriesCTwoPreferredStockMember\n\n2026-03-31\n\n0001417926\n\nIVF:SeriesCTwoPreferredStockMember\n\n2025-12-31\n\n0001417926\n\nus-gaap:SeriesDPreferredStockMember\n\n2026-03-31\n\n0001417926\n\nus-gaap:SeriesDPreferredStockMember\n\n2025-12-31\n\n0001417926\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:ClinicRevenueMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:ClinicRevenueMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:ProductMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:ProductMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:CommonStockMember\n\n2024-12-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nIVF:SeriesCOnePreferredStockMember\n\n2024-12-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nIVF:SeriesCTwoPreferredStockMember\n\n2024-12-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nus-gaap:SeriesDPreferredStockMember\n\n2024-12-31\n\n0001417926\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2024-12-31\n\n0001417926\n\nus-gaap:RetainedEarningsMember\n\n2024-12-31\n\n0001417926\n\n2024-12-31\n\n0001417926\n\nus-gaap:TreasuryStockPreferredMember\nIVF:SeriesCOnePreferredStockMember\n\n2024-12-31\n\n0001417926\n\nus-gaap:TreasuryStockPreferredMember\nIVF:SeriesCTwoPreferredStockMember\n\n2024-12-31\n\n0001417926\n\nus-gaap:CommonStockMember\n\n2025-12-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nIVF:SeriesCOnePreferredStockMember\n\n2025-12-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nIVF:SeriesCTwoPreferredStockMember\n\n2025-12-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nus-gaap:SeriesDPreferredStockMember\n\n2025-12-31\n\n0001417926\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-12-31\n\n0001417926\n\nus-gaap:RetainedEarningsMember\n\n2025-12-31\n\n0001417926\n\nus-gaap:TreasuryStockPreferredMember\nIVF:SeriesCOnePreferredStockMember\n\n2025-12-31\n\n0001417926\n\nus-gaap:TreasuryStockPreferredMember\nIVF:SeriesCTwoPreferredStockMember\n\n2025-12-31\n\n0001417926\n\nus-gaap:CommonStockMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nIVF:SeriesCOnePreferredStockMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nIVF:SeriesCTwoPreferredStockMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nus-gaap:SeriesDPreferredStockMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:RetainedEarningsMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:TreasuryStockPreferredMember\nIVF:SeriesCOnePreferredStockMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:TreasuryStockPreferredMember\nIVF:SeriesCTwoPreferredStockMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:CommonStockMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nIVF:SeriesCOnePreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nIVF:SeriesCTwoPreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nus-gaap:SeriesDPreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:RetainedEarningsMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:TreasuryStockPreferredMember\nIVF:SeriesCOnePreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:TreasuryStockPreferredMember\nIVF:SeriesCTwoPreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:CommonStockMember\n\n2025-03-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nIVF:SeriesCOnePreferredStockMember\n\n2025-03-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nIVF:SeriesCTwoPreferredStockMember\n\n2025-03-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nus-gaap:SeriesDPreferredStockMember\n\n2025-03-31\n\n0001417926\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-03-31\n\n0001417926\n\nus-gaap:RetainedEarningsMember\n\n2025-03-31\n\n0001417926\n\n2025-03-31\n\n0001417926\n\nus-gaap:TreasuryStockPreferredMember\nIVF:SeriesCOnePreferredStockMember\n\n2025-03-31\n\n0001417926\n\nus-gaap:TreasuryStockPreferredMember\nIVF:SeriesCTwoPreferredStockMember\n\n2025-03-31\n\n0001417926\n\nus-gaap:CommonStockMember\n\n2026-03-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nIVF:SeriesCOnePreferredStockMember\n\n2026-03-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nIVF:SeriesCTwoPreferredStockMember\n\n2026-03-31\n\n0001417926\n\nus-gaap:PreferredStockMember\nus-gaap:SeriesDPreferredStockMember\n\n2026-03-31\n\n0001417926\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-03-31\n\n0001417926\n\nus-gaap:RetainedEarningsMember\n\n2026-03-31\n\n0001417926\n\nus-gaap:TreasuryStockPreferredMember\nIVF:SeriesCOnePreferredStockMember\n\n2026-03-31\n\n0001417926\n\nus-gaap:TreasuryStockPreferredMember\nIVF:SeriesCTwoPreferredStockMember\n\n2026-03-31\n\n0001417926\n\nsrt:MinimumMember\n\n2026-03-31\n\n0001417926\n\nsrt:MaximumMember\n\n2026-03-31\n\n0001417926\n\nIVF:MeasurementInputCalibratedDiscountRateMember\n\n2025-12-31\n\n0001417926\n\nus-gaap:FairValueInputsLevel1Member\n\n2025-12-31\n\n0001417926\n\nus-gaap:FairValueInputsLevel2Member\n\n2025-12-31\n\n0001417926\n\nus-gaap:FairValueInputsLevel3Member\n\n2025-12-31\n\n0001417926\n\nus-gaap:FairValueInputsLevel3Member\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:FairValueInputsLevel3Member\n\n2026-03-31\n\n0001417926\n\nus-gaap:EmployeeStockOptionMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:EmployeeStockOptionMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:ConvertibleNotesAndInterestMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:ConvertibleNotesAndInterestMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:ConvertiblePreferredStockMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:ConvertiblePreferredStockMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:WarrantMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:FamilyBeginningsPCMember\n\n2026-02-18\n2026-02-18\n\n0001417926\n\nIVF:FamilyBeginningsPCMember\nus-gaap:SeriesDPreferredStockMember\n\n2026-02-18\n2026-02-18\n\n0001417926\n\nIVF:WoodVioletFertilityLLCMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:WoodVioletFertilityLLCMember\nus-gaap:TradeNamesMember\n\n2026-03-31\n\n0001417926\n\nIVF:WoodVioletFertilityLLCMember\n\n2026-03-31\n\n0001417926\n\nIVF:NAYATherapeuticsMember\n\n2025-06-02\n2025-06-02\n\n0001417926\n\nIVF:NAYATherapeuticsMember\n\n2025-06-02\n\n0001417926\n\nIVF:NAYATherapeuticsMember\nus-gaap:TradeNamesMember\n\n2025-06-02\n\n0001417926\n\nIVF:NAYATherapeuticsMember\nus-gaap:InProcessResearchAndDevelopmentMember\n\n2025-06-02\n\n0001417926\n\nIVF:FamilyBeginningsPCMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:FamilyBeginningsPCMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:BloomInvoLLCMember\nIVF:BloomAgreementMember\n\n2021-06-28\n2021-06-28\n\n0001417926\n\nIVF:BloomInvoLLCMember\n\n2021-06-28\n2021-06-28\n\n0001417926\n\n2021-06-28\n2021-06-28\n\n0001417926\n\nIVF:GeorgiaJVMember\n\n2026-03-31\n\n0001417926\n\nIVF:GeorgiaJVMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:GeorgiaJVMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:AlabamaJvMember\n\n2021-03-10\n2021-03-10\n\n0001417926\n\nIVF:AlabamaJVNoteReceivableMember\n\n2021-03-10\n\n0001417926\n\nIVF:AlabamaJVNoteReceivableMember\n\n2021-03-10\n2021-03-10\n\n0001417926\n\nIVF:AlabamaJVNoteReceivableMember\n\n2026-03-31\n\n0001417926\n\nIVF:AlabamaJVNoteReceivableMember\n\n2025-03-31\n\n0001417926\n\nIVF:AlabamaJvMember\n\n2026-03-31\n\n0001417926\n\nIVF:AlabamaJvMember\n\n2025-03-31\n\n0001417926\n\nIVF:AlabamaJvMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:AlabamaJvMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:HRCFGINVOLLCMember\n\n2026-03-31\n\n0001417926\n\nIVF:HRCFGINVOLLCMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:HRCFGINVOLLCMember\n\n2025-01-01\n2025-12-31\n\n0001417926\n\n2025-01-01\n2025-12-31\n\n0001417926\n\nIVF:HRCFGINVOLLCMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:HRCFGINVOLLCMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:VariableInterestEntityPrimaryBeneficiaryMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:VariableInterestEntityPrimaryBeneficiaryMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:VariableInterestEntityPrimaryBeneficiaryMember\n\n2026-03-31\n\n0001417926\n\nus-gaap:VariableInterestEntityPrimaryBeneficiaryMember\n\n2025-12-31\n\n0001417926\n\nIVF:BloomInvoLLCMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:BloomInvoLLCMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:BloomInvoLLCMember\n\n2026-03-31\n\n0001417926\n\nIVF:BloomInvoLLCMember\n\n2025-12-31\n\n0001417926\n\nus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember\n\n2026-03-31\n\n0001417926\n\nus-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember\n\n2025-12-31\n\n0001417926\n\nIVF:NAYATherapeuticsIncMember\n\n2025-06-01\n\n0001417926\n\nIVF:NAYATherapeuticsIncMember\n\n2025-05-28\n2025-05-28\n\n0001417926\n\nIVF:NAYATherapeuticsIncMember\n\n2025-05-28\n\n0001417926\n\nIVF:NAYATherapeuticsMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:ManufacturingEquipmentMember\nsrt:MinimumMember\n\n2026-03-31\n\n0001417926\n\nIVF:ManufacturingEquipmentMember\nsrt:MinimumMember\n\n2025-12-31\n\n0001417926\n\nIVF:ManufacturingEquipmentMember\nsrt:MaximumMember\n\n2026-03-31\n\n0001417926\n\nIVF:ManufacturingEquipmentMember\nsrt:MaximumMember\n\n2025-12-31\n\n0001417926\n\nIVF:MedicalEquipmentMember\nsrt:MinimumMember\n\n2026-03-31\n\n0001417926\n\nIVF:MedicalEquipmentMember\nsrt:MinimumMember\n\n2025-12-31\n\n0001417926\n\nIVF:MedicalEquipmentMember\nsrt:MaximumMember\n\n2026-03-31\n\n0001417926\n\nIVF:MedicalEquipmentMember\nsrt:MaximumMember\n\n2025-12-31\n\n0001417926\n\nsrt:MinimumMember\nus-gaap:OfficeEquipmentMember\n\n2026-03-31\n\n0001417926\n\nsrt:MinimumMember\nus-gaap:OfficeEquipmentMember\n\n2025-12-31\n\n0001417926\n\nsrt:MaximumMember\nus-gaap:OfficeEquipmentMember\n\n2026-03-31\n\n0001417926\n\nsrt:MaximumMember\nus-gaap:OfficeEquipmentMember\n\n2025-12-31\n\n0001417926\n\nIVF:ManufacturingEquipmentMember\n\n2026-03-31\n\n0001417926\n\nIVF:ManufacturingEquipmentMember\n\n2025-12-31\n\n0001417926\n\nIVF:MedicalEquipmentMember\n\n2026-03-31\n\n0001417926\n\nIVF:MedicalEquipmentMember\n\n2025-12-31\n\n0001417926\n\nus-gaap:OfficeEquipmentMember\n\n2026-03-31\n\n0001417926\n\nus-gaap:OfficeEquipmentMember\n\n2025-12-31\n\n0001417926\n\nus-gaap:LeaseholdImprovementsMember\n\n2026-03-31\n\n0001417926\n\nus-gaap:LeaseholdImprovementsMember\n\n2025-12-31\n\n0001417926\n\nIVF:FertilityClinicServicesMember\n\n2025-12-31\n\n0001417926\n\nus-gaap:GoodwillMember\n\n2025-12-31\n\n0001417926\n\nIVF:FertilityClinicServicesMember\n\n2025-01-01\n2025-12-31\n\n0001417926\n\nus-gaap:GoodwillMember\n\n2025-01-01\n2025-12-31\n\n0001417926\n\nIVF:FertilityClinicServicesMember\n\n2026-03-31\n\n0001417926\n\nus-gaap:GoodwillMember\n\n2026-03-31\n\n0001417926\n\nIVF:WisconsinFertilityInstituteAcquisitionMember\nus-gaap:TradeNamesMember\n\n2023-08-10\n2023-08-10\n\n0001417926\n\nIVF:WisconsinFertilityInstituteAcquisitionMember\nus-gaap:NoncompeteAgreementsMember\n\n2023-08-10\n2023-08-10\n\n0001417926\n\nIVF:WisconsinFertilityInstituteAcquisitionMember\n\n2023-08-10\n2023-08-10\n\n0001417926\n\nIVF:WisconsinFertilityInstituteAcquisitionMember\nIVF:AssembledWorkforceMember\n\n2023-08-10\n2023-08-10\n\n0001417926\n\nIVF:WisconsinFertilityInstituteAcquisitionMember\nus-gaap:TradeNamesMember\n\n2023-08-10\n\n0001417926\n\nIVF:WisconsinFertilityInstituteAcquisitionMember\nus-gaap:NoncompeteAgreementsMember\n\n2023-08-10\n\n0001417926\n\nus-gaap:NoncompeteAgreementsMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\n\n2026-03-31\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\n\n2025-12-31\n\n0001417926\n\nIVF:RelatedPartyConvertibleNotesMember\n\n2026-03-31\n\n0001417926\n\nIVF:RelatedPartyConvertibleNotesMember\n\n2025-12-31\n\n0001417926\n\nus-gaap:ConvertibleNotesPayableMember\n\n2026-03-31\n\n0001417926\n\nus-gaap:ConvertibleNotesPayableMember\n\n2025-12-31\n\n0001417926\n\nIVF:NotePayableMember\n\n2026-03-31\n\n0001417926\n\nIVF:NotePayableMember\n\n2025-12-31\n\n0001417926\n\nIVF:NotePayableMember\nsrt:MinimumMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:NotePayableMember\nsrt:MinimumMember\n\n2025-01-01\n2025-12-31\n\n0001417926\n\nIVF:NotePayableMember\nsrt:MaximumMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:NotePayableMember\nsrt:MaximumMember\n\n2025-01-01\n2025-12-31\n\n0001417926\n\nIVF:NotePayableMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:NotePayableMember\n\n2025-01-01\n2025-12-31\n\n0001417926\n\nIVF:JAGMultiInvestmentsLLCMember\n\n2022-12-31\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\n\n2023-07-10\n2023-07-10\n\n0001417926\n\nIVF:JAGAmendmentMember\nIVF:RelatedPartyDemandNotesMember\n\n2025-08-13\n2025-08-13\n\n0001417926\n\nIVF:JAGAugustLetterMember\n\n2025-08-13\n2025-08-13\n\n0001417926\n\nIVF:JAGMultiInvestmentsLLCMember\nIVF:JAGAmendmentMember\n\n2025-11-13\n2025-11-13\n\n0001417926\n\nIVF:JAGMultiInvestmentsLLCMember\nIVF:JAGAmendmentMember\n\n2025-11-12\n2025-11-12\n\n0001417926\n\nIVF:JAGMultiInvestmentsLLCMember\nIVF:JAGAmendmentMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:JAGMultiInvestmentsLLCMember\nIVF:JAGAmendmentMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:JAGMultiInvestmentsLLCMember\nIVF:JAGAmendmentMember\n\n2025-12-01\n2025-12-31\n\n0001417926\n\nIVF:JAGMultiInvestmentsLLCMember\nIVF:JAGAmendmentMember\n\n2026-03-31\n\n0001417926\n\nIVF:JAGMultiInvestmentsLLCMember\nIVF:JAGAmendmentMember\n\n2025-12-31\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\n\n2022-10-01\n2022-12-31\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\nsrt:ChiefExecutiveOfficerMember\n\n2022-10-01\n2022-12-31\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\nsrt:ChiefExecutiveOfficerMember\n\n2022-11-29\n2022-11-29\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\nsrt:ChiefExecutiveOfficerMember\n\n2022-12-02\n2022-12-02\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\nsrt:ChiefExecutiveOfficerMember\n\n2022-12-13\n2022-12-13\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\nsrt:ChiefFinancialOfficerMember\n\n2022-10-01\n2022-12-31\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\nsrt:ChiefFinancialOfficerMember\n\n2022-11-29\n2022-11-29\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\nsrt:ChiefFinancialOfficerMember\n\n2022-12-13\n2022-12-13\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\n\n2022-12-31\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:RevenueLoanAndSecurityAgreementMember\n\n2023-09-29\n\n0001417926\n\nIVF:RevenueLoanAndSecurityAgreementMember\n\n2023-09-29\n2023-09-29\n\n0001417926\n\nIVF:RevenueLoanAndSecurityAgreementMember\n\n2024-11-30\n\n0001417926\n\nIVF:RevenueLoanAndSecurityAgreementMember\n\n2025-08-13\n2025-08-13\n\n0001417926\n\nIVF:RevenueLoanAndSecurityAgreementMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:RevenueLoanAndSecurityAgreementMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:RevenueLoanAndSecurityAgreementMember\n\n2026-03-31\n\n0001417926\n\nIVF:RevenueLoanAndSecurityAgreementMember\n\n2025-03-31\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\nIVF:JAGMultiInvestmentsLLCMember\n\n2022-12-31\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\nIVF:JAGMultiInvestmentsLLCMember\n\n2022-10-01\n2022-12-31\n\n0001417926\n\nIVF:JAGMultiInvestmentsLLCMember\nIVF:RelatedPartyDemandNotesMember\n\n2023-07-10\n\n0001417926\n\nIVF:JAGMultiInvestmentsLLCMember\nIVF:RelatedPartyDemandNotesMember\n\n2023-07-10\n2023-07-10\n\n0001417926\n\nIVF:JAGMultiInvestmentsLLCMember\nIVF:RelatedPartyDemandNotesMember\n\n2022-12-29\n2022-12-29\n\n0001417926\n\nIVF:RelatedPartyDemandNotesMember\nIVF:JAGMultiInvestmentsLLCMember\n\n2022-12-29\n\n0001417926\n\nIVF:JAGAmendmentMember\n\n2025-08-13\n2025-08-13\n\n0001417926\n\nIVF:BoardOfDirectorsMember\n\n2026-03-24\n\n0001417926\n\nIVF:BoardOfDirectorsMember\n\n2026-03-25\n\n0001417926\n\nIVF:BoardOfDirectorsMember\n\n2026-03-25\n2026-03-25\n\n0001417926\n\n2026-01-22\n\n0001417926\n\n2026-01-23\n\n0001417926\n\nIVF:BoardOfDirectorsMember\nsrt:MaximumMember\n\n2025-11-26\n\n0001417926\n\nIVF:BoardOfDirectorsMember\nsrt:MinimumMember\n\n2025-11-26\n\n0001417926\n\nIVF:BoardOfDirectorsMember\n\n2025-11-26\n2025-11-26\n\n0001417926\n\n2025-07-22\n\n0001417926\n\n2025-07-23\n\n0001417926\n\nIVF:BoardOfDirectorsMember\n\n2025-02-24\n\n0001417926\n\nIVF:BoardOfDirectorsMember\n\n2025-02-23\n\n0001417926\n\nIVF:BoardOfDirectorsMember\n\n2025-03-18\n2025-03-18\n\n0001417926\n\nIVF:SeriesCTwoConvertiblePreferredStockMember\nus-gaap:PreferredStockMember\n\n2024-10-14\n\n0001417926\n\nIVF:SeriesCTwoConvertiblePreferredStockMember\n\n2024-10-14\n\n0001417926\n\nIVF:SeriesCTwoConvertiblePreferredStockMember\nus-gaap:OtherInvesteesMember\n\n2024-10-14\n\n0001417926\n\nIVF:SeriesCTwoConvertiblePreferredStockMember\n\n2024-10-14\n2024-10-14\n\n0001417926\n\nIVF:SeriesCTwoPreferredStockMember\n\n2025-06-27\n\n0001417926\n\nus-gaap:SeriesDPreferredStockMember\n\n2026-02-18\n\n0001417926\n\nIVF:SevenPercentageSecuredConvertibleDebentureMember\n\n2026-02-16\n\n0001417926\n\nIVF:SeriesCTwoPreferredStockMember\n\n2025-05-23\n\n0001417926\n\nIVF:SeriesCTwoPreferredStockMember\nIVF:FiveNarrowLaneLPMember\n\n2025-05-23\n2025-05-23\n\n0001417926\n\nIVF:SeriesCTwoConvertiblePreferredStockMember\nus-gaap:PreferredStockMember\n\n2025-06-26\n\n0001417926\n\nIVF:SeriesCTwoPreferredStockMember\n\n2025-06-26\n\n0001417926\n\nIVF:SeriesCTwoConvertiblePreferredStockMember\n\n2025-06-26\n\n0001417926\n\nIVF:SeriesCTwoPreferredStockMember\n\n2025-06-30\n\n0001417926\n\nIVF:AIRExerciseAndReloadAgreementMember\n\n2025-06-30\n2025-06-30\n\n0001417926\n\nIVF:AIRExerciseAndReloadAgreementMember\n\n2025-06-30\n\n0001417926\n\nIVF:AIRExerciseAndReloadAgreementMember\nIVF:SeriesCTwoPreferredStockMember\n\n2025-06-30\n2025-06-30\n\n0001417926\n\nIVF:MayTwoThousandTwentyFiveAmendedAndRestatedDebentureMember\n\n2025-05-23\n2025-05-23\n\n0001417926\n\nIVF:SeriesCTwoConvertiblePreferredStockMember\nus-gaap:PreferredStockMember\n\n2025-09-30\n\n0001417926\n\nIVF:SeriesCTwoPreferredStockMember\nus-gaap:PreferredStockMember\n\n2025-09-30\n\n0001417926\n\nIVF:SeriesCTwoPreferredStockMember\n\n2025-09-30\n\n0001417926\n\nIVF:SeriesCTwoConvertiblePreferredStockMember\n\n2025-09-30\n\n0001417926\n\nIVF:AugustTwoThousandTwentyFiveAmendedAndRestatedDebentureMember\nIVF:SeriesCTwoPreferredStockMember\n\n2025-08-21\n2025-08-21\n\n0001417926\n\nIVF:AugustTwoThousandTwentyFiveAmendedAndRestatedDebentureMember\nIVF:SeriesCTwoPreferredStockMember\n\n2025-08-21\n\n0001417926\n\nIVF:AugustTwoThousandTwentyFiveAmendedAndRestatedDebentureMember\nIVF:SeriesCTwoPreferredStockMember\n\n2025-09-29\n\n0001417926\n\nIVF:AugustTwoThousandTwentyFiveAmendedAndRestatedDebentureMember\nIVF:SeriesCTwoPreferredStockMember\n\n2025-09-29\n2025-09-29\n\n0001417926\n\nIVF:AugustTwoThousandTwentyFiveAmendedAndRestatedDebentureMember\n\n2025-09-29\n2025-09-29\n\n0001417926\n\nIVF:SeriesCTwoPreferredStockMember\nIVF:AugustTwoThousandTwentyFiveAmendedAndRestatedDebentureMember\n\n2025-10-01\n2025-12-31\n\n0001417926\n\nIVF:SeriesCTwoPreferredStockMember\nIVF:AugustTwoThousandTwentyFiveAmendedAndRestatedDebentureMember\n\n2025-12-31\n\n0001417926\n\n2025-01-14\n2025-01-14\n\n0001417926\n\nus-gaap:CommonStockMember\n\n2025-01-14\n\n0001417926\n\nus-gaap:WarrantMember\n\n2025-01-14\n\n0001417926\n\nIVF:PreFundedWarrantsMember\n\n2025-01-14\n\n0001417926\n\n2025-01-13\n2025-01-13\n\n0001417926\n\n2025-01-13\n\n0001417926\n\n2025-01-01\n2025-01-31\n\n0001417926\n\nIVF:SeriesCTwoConvertiblePreferredStockMember\n\n2025-01-01\n2025-01-31\n\n0001417926\n\nus-gaap:CommonStockMember\nIVF:SecuritiesPurchaseAgreementMember\n\n2025-12-02\n2025-12-02\n\n0001417926\n\nIVF:PreFundedWarrantsMember\nIVF:SecuritiesPurchaseAgreementMember\n\n2025-12-02\n\n0001417926\n\nIVF:CommonWarrantsMember\nIVF:SecuritiesPurchaseAgreementMember\n\n2025-12-02\n\n0001417926\n\nus-gaap:CommonStockMember\nIVF:SecuritiesPurchaseAgreementMember\n\n2025-12-02\n\n0001417926\n\nIVF:SecuritiesPurchaseAgreementMember\nIVF:DecemberTwoThousandTwentyFivePrivatePlacementMember\n\n2025-12-02\n2025-12-02\n\n0001417926\n\nIVF:SecuritiesPurchaseAgreementMember\nIVF:DecemberTwoThousandTwentyFivePrivatePlacementMember\n\n2025-12-02\n\n0001417926\n\nIVF:PreFundedWarrantsMember\n\n2026-01-01\n2026-01-31\n\n0001417926\n\nIVF:FNLWarrantsMember\n\n2026-01-01\n2026-01-31\n\n0001417926\n\nIVF:FNLWarrantsMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:CommonStockMember\nIVF:TwoThousandNineteenStockIncentivePlanMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:TwoThousandNineteenStockIncentivePlanMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:StockIncentivePlanMember\n\n2025-06-25\n\n0001417926\n\nIVF:TwoThousandNineteenStockIncentivePlanMember\nsrt:MinimumMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:TwoThousandNineteenStockIncentivePlanMember\nsrt:MaximumMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:StockCompensationPlanMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:PreFundedWarrantsMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:PreFundedWarrantsMember\n\n2025-12-31\n\n0001417926\n\nIVF:PreFundedWarrantsMember\n\n2026-03-31\n\n0001417926\n\nIVF:PrefundedWarrantMember\n\n2025-01-31\n\n0001417926\n\nus-gaap:CommonStockMember\nIVF:InducementLetterAgreementMember\n\n2025-04-30\n2025-04-30\n\n0001417926\n\nIVF:InducementLetterAgreementMember\n\n2025-01-14\n\n0001417926\n\nIVF:InducementLetterAgreementMember\n\n2025-04-30\n2025-04-30\n\n0001417926\n\nIVF:InducementLetterAgreementMember\nIVF:NewWarrantMember\n\n2025-06-25\n\n0001417926\n\nIVF:NewWarrantMember\n\n2025-01-01\n2025-12-31\n\n0001417926\n\nIVF:JAGAmendmentMember\n\n2025-08-13\n\n0001417926\n\nIVF:JAGAmendmentMember\n\n2025-11-13\n2025-11-13\n\n0001417926\n\nIVF:December2025WarrantsMember\n\n2025-12-31\n\n0001417926\n\nIVF:December2025WarrantsMember\n\n2025-01-01\n2025-12-31\n\n0001417926\n\nIVF:December2025WarrantsMember\n\n2026-01-22\n2026-01-22\n\n0001417926\n\nIVF:InducementLetterAgreementMember\nIVF:NewWarrantMember\n\n2026-01-28\n\n0001417926\n\nIVF:InducementLetterAgreementMember\nIVF:NewWarrantMember\n\n2026-01-26\n\n0001417926\n\nIVF:NoCustomersMember\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:NoCustomersMember\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:NoCustomersMember\nus-gaap:AccountsReceivableMember\nus-gaap:CustomerConcentrationRiskMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:NoCustomersMember\nus-gaap:AccountsReceivableMember\nus-gaap:CustomerConcentrationRiskMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:FertilityClinicServicesMember\nus-gaap:OperatingSegmentsMember\nIVF:RevenueFromExternalCustomersMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:InvocellDeviceMember\nus-gaap:OperatingSegmentsMember\nIVF:RevenueFromExternalCustomersMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:OperatingSegmentsMember\nIVF:RevenueFromExternalCustomersMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:FertilityClinicServicesMember\nus-gaap:OperatingSegmentsMember\nIVF:InterSegmentRevenueMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:InvocellDeviceMember\nus-gaap:OperatingSegmentsMember\nIVF:InterSegmentRevenueMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:OperatingSegmentsMember\nIVF:InterSegmentRevenueMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:FertilityClinicServicesMember\nus-gaap:OperatingSegmentsMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:InvocellDeviceMember\nus-gaap:OperatingSegmentsMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nus-gaap:OperatingSegmentsMember\n\n2026-01-01\n2026-03-31\n\n0001417926\n\nIVF:FertilityClinicServicesMember\n\n2026-03-31\n\n0001417926\n\nIVF:InvocellDeviceMember\n\n2026-03-31\n\n0001417926\n\nIVF:FertilityClinicServicesMember\nus-gaap:OperatingSegmentsMember\nIVF:RevenueFromExternalCustomersMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:InvocellDeviceMember\nus-gaap:OperatingSegmentsMember\nIVF:RevenueFromExternalCustomersMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:TherapeuticsMember\nus-gaap:OperatingSegmentsMember\nIVF:RevenueFromExternalCustomersMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:OperatingSegmentsMember\nIVF:RevenueFromExternalCustomersMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:FertilityClinicServicesMember\nus-gaap:OperatingSegmentsMember\nIVF:InterSegmentRevenueMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:InvocellDeviceMember\nus-gaap:OperatingSegmentsMember\nIVF:InterSegmentRevenueMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:TherapeuticsMember\nus-gaap:OperatingSegmentsMember\nIVF:InterSegmentRevenueMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:OperatingSegmentsMember\nIVF:InterSegmentRevenueMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:FertilityClinicServicesMember\nus-gaap:OperatingSegmentsMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:InvocellDeviceMember\nus-gaap:OperatingSegmentsMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:TherapeuticsMember\nus-gaap:OperatingSegmentsMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nus-gaap:OperatingSegmentsMember\n\n2025-01-01\n2025-03-31\n\n0001417926\n\nIVF:FertilityClinicServicesMember\n\n2025-03-31\n\n0001417926\n\nIVF:InvocellDeviceMember\n\n2025-03-31\n\n0001417926\n\nIVF:TherapeuticsMember\n\n2025-03-31\n\n0001417926\n\nIVF:JAGNotesMember\n\n2025-05-27\n2025-05-27\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\nxbrli:pure\n\nIVF:Integer\n\nIVF:Segments\n\n \n\n \n\n \n\n**UNITED\nSTATES**\n\n**SECURITIES\nAND EXCHANGE COMMISSION**\n\n**Washington,\nD.C. 20549**\n\n \n\n \n\n \n\n**FORM\n10-Q**\n\n \n\n \n\n \n\n☒\n**QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**For\nthe quarterly period ended March 31, 2026**\n\n \n\n**OR**\n\n \n\n☐\n**TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**For\nthe transition period from ________________ to ________________**\n\n \n\n**Commission\nFile Number: 001-39701**\n\n \n\n**INVO\nFertility, Inc.**\n\n(Exact\nName of Registrant as Specified in its Charter)\n\n \n\n**Nevada**\n \n**20-4036208**\n\n(State\nor other jurisdiction\n\nof\nincorporation or organization)\n\n \n\n(I.R.S.\nEmployer\n\nIdentification\nNo.)\n\n \n\n**5582\nBroadcast Court**\n \n \n\n**Sarasota,\nFL**\n \n**34240**\n\n(Address\nof principal executive offices)\n \n(Zip\nCode)\n\n \n\n**(978)\n878-9505**\n\n(Registrant’s\ntelephone number, including area code)\n\n \n\nSecurities\nregistered pursuant to Section 12(b) of the Act:\n\n \n\nTitle\nof each class\n \nTrading\nsymbol(s)\n \nName\nof each exchange on which registered\n\n**Common\nStock, $0.0001 par value per share**\n \n**IVF**\n \n**The\nNasdaq Stock Market LLC**\n\n \n\nIndicate\nby check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange\nAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)\nhas been subject to such filing requirements for the past 90 days. Yes ☒ No ☐\n\n \n\nIndicate\nby check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule\n405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant\nwas required to submit such files). Yes ☒ No ☐\n\n \n\nIndicate\nby check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting\ncompany or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”\n“smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge\naccelerated filer ☐\n \nAccelerated\nfiler ☐\n \n \n\nNon-accelerated\nfiler ☒\n \nSmaller\nreporting company ☒\n \nEmerging\ngrowth company ☐\n\n \n\nIf\nan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate\nby check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\n \n\nAs\nof June 22, 2026, the Registrant had 1,786,035 shares of common stock outstanding.\n\n \n\n \n\n \n\n \n\n \n\n** **\n\n**INVO\nFERTILITY, INC. FORM 10-Q**\n\n**FOR\nTHE QUARTERLY PERIOD ENDED MARCH 31, 2026**\n\n \n\n**TABLE\nOF CONTENTS**\n\n \n\n**Item**\n \n**Page\nNumber**\n\n**PART\nI. FINANCIAL INFORMATION**\n \n\n \n \n \n\n1.\n[Financial\nStatements (Unaudited):](#ta_002)\n4\n\n \n[Consolidated\nBalance Sheet as of March 31, 2026 (Unaudited) and December 31, 2025](#ta_003)\n4\n\n \n[Consolidated\nStatements of Operations for the three months ended March 31, 2026 and 2025 (Unaudited)](#ta_004)\n5\n\n \n[Consolidated\nStatements of Stockholders’ Equity for the three months ended March 31, 2026 and 2025 (Unaudited)](#ta_005)\n6\n\n \n[Consolidated\nStatements of Cash Flows for the three months ended March 31, 2026 and 2025 (Unaudited)](#ta_006)\n7\n\n \n[Notes\nto the Consolidated Financial Statements](#ta_007)\n8\n\n2.\n[Management’s\nDiscussion and Analysis of Financial Condition and Results of Operations](#ta_008)\n29\n\n3.\n[Quantitative\nand Qualitative Disclosures about Market Risks](#ta_009)\n38\n\n4.\n[Controls\nand Procedures](#ta_010)\n38\n\n \n \n \n\n**PART\nII. OTHER INFORMATION**\n \n\n \n \n \n\n1.\n[Legal\nProceedings](#ta_012)\n39\n\n1A.\n[Risk\nFactors](#ta_013)\n39\n\n2.\n[Unregistered\nSales of Equity Securities and Use of Proceeds](#ta_014)\n39\n\n3.\n[Defaults\nUpon Senior Securities](#ta_015)\n39\n\n4.\n[Mine\nSafety Disclosure](#ta_016)\n39\n\n5.\n[Other\nInformation](#ta_017)\n39\n\n6.\n[Exhibits](#ta_018)\n40\n\n \n[Signatures](#ta_019)\n41\n\n \n\n2\n\n \n\n** **\n\n**CAUTIONARY\nNOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA**\n\n \n\nThis\nQuarterly Report on Form 10-Q contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A\nof the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934,\nas amended (the “Exchange Act”). These statements may be identified by such forward-looking terminology as “may,”\n“should,” “expects,” “intends,” “plans,” “anticipates,” “believes,”\n“estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other\ncomparable terminology. Our forward-looking statements are based on a series of expectations, assumptions, estimates, and projections\nabout our company, are not guarantees of future results or performance, and involve substantial risks and uncertainty. We may not actually\nachieve the plans, intentions, or expectations disclosed in these forward-looking statements. Actual results or events could differ materially\nfrom the plans, intentions, and expectations disclosed in these forward-looking statements. Our business and our forward-looking statements\ninvolve substantial known and unknown risks and uncertainties, including the risks and uncertainties inherent in our statements regarding\nthe following:\n\n \n\n●Our\nfinancial condition and need for additional capital;\n\n   \n\n●Our\nlimited operating history and a history of net operating losses, and we depend on continued\naccess to capital and clinic revenue growth to fund our operations;\n\n   \n\n●The\ncompetitiveness of the fertility and ART services industry;\n\n   \n\n●The\ndependence of our growth strategy on identifying and successfully completing and integrating\nfertility clinic acquisition;\n\n   \n\n●Our\ndependence on key executives, physicians, embryologists, and clinical personnel;\n\n   \n\n●Risks\nassociated with operating certain of our fertility clinics as joint ventures;\n\n   \n\n●Reliance\non a single third-party manufacturer for INVOcell production;\n\n   \n\n●Intellectual\nproperty risks;\n\n   \n\n●Evolving\nstate and federal laws on abortion and embryo personhood;\n\n   \n\n●Federal\nand state regulation as both a fertility clinic operator and a medical device manufacturer;\n\n   \n\n●The\nFDA clearance process for the INVOcell and any future device modifications;\n\n   \n\n●Payor\nconsolidation and managed care trends;\n\n   \n\n●Cybersecurity\nthreats or data breaches involving sensitive patient health information;\n\n   \n\n●Material\nweaknesses in our internal control over financial reporting;\n\n   \n\n●Risks\nrelated to our common stock and capital structure; and\n\n   \n\n●Risks\nrelated to market and macroeconomic conditions.\n\n \n\nAll\nof our forward-looking statements are as of the date of this Quarterly Report on Form 10-Q only. In each case, actual results may differ\nmaterially from such forward-looking information. We can give no assurance that such expectations or forward-looking statements will\nprove to be correct. An occurrence of, or any material adverse change in, one or more of the risk factors or risks and uncertainties\nreferred to in this Quarterly Report on Form 10-Q or included in our other public disclosures or our other periodic reports or other\ndocuments or filings filed with or furnished to the U.S. Securities and Exchange Commission (the “SEC”) could materially\nand adversely affect our business, prospects, financial condition and results of operations. Except as required by law, we do not undertake\nor plan to update or revise any such forward-looking statements to reflect actual results, changes in plans, assumptions, estimates,\nor projections or other circumstances affecting such forward-looking statements occurring after the date of this Quarterly Report on\nForm 10-Q, even if such results, changes, or circumstances make it clear that any forward-looking information will not be realized. Any\npublic statements or disclosures by us following this Quarterly Report on Form 10-Q that modify or impact any of the forward-looking\nstatements contained in this Quarterly Report on Form 10-Q will be deemed to modify or supersede such statements in this Quarterly Report\non Form 10-Q.\n\n \n\nThis\nQuarterly Report on Form 10-Q may include market data and certain industry data and forecasts, which we may obtain from internal company\nsurveys, market research, consultant surveys, publicly available information, reports of governmental agencies, and industry publications,\narticles, and surveys. Industry surveys, publications, consultant surveys, and forecasts generally state that the information contained\ntherein has been obtained from sources believed to be reliable, but the accuracy and completeness of such information is not guaranteed.\nWhile we believe that such studies and publications are reliable, we have not independently verified market and industry data from third-party\nsources.\n\n \n\n3\n\n \n\n** **\n\n**PART\nI. FINANCIAL INFORMATION**"}